GLP-1的故事里，中国玩家终于又交上了新答卷。 最近，银诺医药自研的长效GLP-1药物依苏帕格鲁肽α注射液（商品名“怡诺轻”）获国家药监局批准上市，用于治疗成人2型糖尿病。2月11日，“怡诺轻”在线下公立医院开出了全国首张处方。 据悉，依苏帕格鲁肽α已经在京东健康、阿里健康两大电商平台开启预约，并将于2月18日正式首发，线上开售。 2021年左右，诺和诺德的司美格鲁肽“点燃”全球GLP-1市场之 ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative. The stock is reasonably valued given the growth opportunities in front ...

When Aja Beckett started using a GLP-1 medication, she took notes on her phone ... nausea peaked at different lengths of time after her shot, and by logging her doses, she could estimate when ...

Working with a weight management program can help sustain the use of GLP-1 therapies and address potential side effects. Patient education and expectation management are crucial for maximizing ...

A once weekly injection of semaglutide, the main ingredient in Ozempic and Wegovy, may help problem drinkers kick their cravings.In a new study, the drug, known ...

When Trova Wine and Market shut its doors last month after nearly five years in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like Ozempic.

The company has been a big beneficiary of GLP-1 drugs that have seen soaring demand as they have been shown to greatly help with multiple health issues, including weight control. The stock has ...

To assess the impact of GLP-1 agonists on incidence and management of adhesive capsulitis, Bergstein and colleagues used the PearlDiver database to perform a retrospective cohort comparison of ...

However, the trial was halted prematurely and the data should be interpreted with caution. The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional ...